BiO2 Medical is a medical device manufacturer founded to design, develop, and subsequently manufacture a range of medical products in response to clinical needs. BiO2 Medical’s current primary objective is to develop and commercialize the Angel™ Catheter as the de facto standard of care device for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide. This proven team of technical staff is supported by management and advisors who have worked together for 10 years and have extensive experience in: medical device development, product commercialization, and patent portfolio creation.Read More!
BiO2 Medical is proud to introduce the Angel™ Catheter, a novel catheter-based IVC filter that addresses a substantial unmet need in the prevention of Pulmonary Embolism (PE) in critical care patients. This truly retrievable Vena Cava Filter is permanently attached to a multi-lumen central venous catheter and provides a compelling clinical and value proposition to hospitals and critical care physicians while complying with ACCP, FDA, & CMS guidelines.Read More!
BiO2 Medical is focused on decreasing the incidence of hospital acquired complications among critically ill patients by providing new devices that can be easily implemented in clinical practice in response to medical needs.
BiO2 Medical, Inc. was founded in December 2006 by Luis F. Angel, MD, Christopher E. Banas, and Paul Castella, PhD. The company was formed to design, develop, and subsequently manufacture a range of medical products.
BiO2 Medical has corporate headquarters in San Antonio, TX, and a research and development (R&D) and manufacturing facility in Golden, CO. The Golden facility is certified per ISO 13485:2003 and includes a state of the art 1,000 ft2 clean room certified as a class 8 (100,000) controlled environment (CER), which is currently dedicated to the production of the Angel™ Catheter.